Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Curcumin + coenzyme Q10 is a fixed-dose combination dietary supplement containing two bioactive compounds—curcumin (the principal curcuminoid of turmeric) and coenzyme Q10 (ubiquinone). Curcumin is known for its anti-inflammatory, antioxidant, and potential lipid-lowering properties. It acts by inhibiting cyclooxygenase 2 (COX-2), modulating inflammatory pathways, and scavenging free radicals. However, its clinical utility is limited by low oral bioavailability due to rapid metabolism. Coenzyme Q10 is a mitochondrial electron transport chain component with antioxidant activity; it supports cellular energy production and may reduce oxidative stress. The combination aims to synergistically enhance anti-inflammatory effects, improve mitochondrial function, support cardiovascular health (including cholesterol management), reduce migraine severity/frequency in some studies, and potentially provide neuroprotective benefits[1][2][4][5][6]. Formulations often include excipients like phospholipids or medium-chain triglycerides to improve absorption.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on curcumin + coenzyme q10.